Sinocare Enters Into Definitive Agreement to Acquire PTS | 合法醫療器材資訊網

2016年5月2日—CHANGSHA,China,May02,2016(GLOBENEWSWIRE)--SinocareInc....PTSDiagnosticsisaU.S.-basedmanufacturerofpoint-of-care ...

CHANGSHA, China, May 02, 2016 (GLOBE NEWSWIRE) -- Sinocare Inc. (San Nuo Sheng Wu) (SHE:300298), announced today it has signed a definitive purchase agreement with privately-held PTS Diagnostics, under which Sinocare will acquire PTS Diagnostics for up to $200 million in cash including contingent considerations of up to $90 million for the successful accomplishment of certain milestones.  PTS Diagnostics is a U.S.-based manufacturer of point-of-care biometric testing devices, including the CardioChek® family of analyzers, A1CNow® systems, and PTS Detect™ cotinine systems. The company’s manufacturing facilities are principally located in Indianapolis, IN and Sunnyvale, CA.

Shaobo Li, Chairman and CEO of Sinocare commented, “Sinocare is dedicated to the innovation of biosensor technology and has been providing high quality products and services to people with diabetes and other chronic d...